US Launches Trade Probe into German Pharma Pricing, Tariffs Possible
The US has initiated a Section 301 trade investigation into Germany's pharmaceutical pricing policies, alleging they unfairly burden US commerce and force the US to fund a disproportionate share of global drug R&D, potentially leading to new tariffs.

















